---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-204231"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:29:49.251830+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oscar Health prices $355M 2.25% convertible notes due 2030; uses proceeds for growth and AI

## Summary
- Upsized offering of $355M (from $350M); 2.25% interest, due September 1, 2030.
- Net proceeds ~$342.5M (or ~$395.8M if initial purchasers exercise $55M option).
- Initial conversion price $24.82/share, a 32.5% premium to $18.73 closing price.
- Capped call transactions with cap at $37.46/share (100% premium) to reduce dilution.
- Will terminate revolving credit facility contingent on closing of the offering.

## SEC filing metadata
- accession: 0001193125-25-204231
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312525204231/0001193125-25-204231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312525204231/d944721d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-204231
- JSON: https://secwatch.observer/filing/0001193125-25-204231.json
- Plain text: https://secwatch.observer/filing/0001193125-25-204231.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.